These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 15878004)
1. Influence of the randomized trials, AFFIRM and RACE, on the management of atrial fibrillation in two University Medical Centers. Mason PK; Wood MA; Lake D; Dimarco JP Am J Cardiol; 2005 May; 95(10):1248-50. PubMed ID: 15878004 [TBL] [Abstract][Full Text] [Related]
2. AFFIRM and RACE trials: implications for the management of atrial fibrillation. Blackshear JL; Safford RE; ; Card Electrophysiol Rev; 2003 Dec; 7(4):366-9. PubMed ID: 15071255 [TBL] [Abstract][Full Text] [Related]
3. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Jenkins LS; Brodsky M; Schron E; Chung M; Rocco T; Lader E; Constantine M; Sheppard R; Holmes D; Mateski D; Floden L; Prasun M; Greene HL; Shemanski L Am Heart J; 2005 Jan; 149(1):112-20. PubMed ID: 15660042 [TBL] [Abstract][Full Text] [Related]
4. Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study. Hagens VE; Vermeulen KM; TenVergert EM; Van Veldhuisen DJ; Bosker HA; Kamp O; Kingma JH; Tijssen JG; Crijns HJ; Van Gelder IC; Eur Heart J; 2004 Sep; 25(17):1542-9. PubMed ID: 15342174 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management trial on prescribing patterns: a time-series analysis. Choudhry NK; Zagorski B; Avorn J; Levin R; Sykora K; Laupacis A; Mamdani M Ann Pharmacother; 2008 Nov; 42(11):1563-72. PubMed ID: 18827174 [TBL] [Abstract][Full Text] [Related]
6. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. Rienstra M; Van Veldhuisen DJ; Hagens VE; Ranchor AV; Veeger NJ; Crijns HJ; Van Gelder IC; J Am Coll Cardiol; 2005 Oct; 46(7):1298-306. PubMed ID: 16198847 [TBL] [Abstract][Full Text] [Related]
7. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088 [TBL] [Abstract][Full Text] [Related]
8. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation. Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494 [TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of patients with persistent atrial fibrillation referred for cardioversion: Spanish Cardioversion Registry (REVERSE)]. Alegret JM; Viñolas X; Sagristá J; Hernández-Madrid A; Berruezo A; Moya A; Martínez Sande JL; Pastor A; Rev Esp Cardiol; 2008 Jun; 61(6):630-4. PubMed ID: 18570785 [TBL] [Abstract][Full Text] [Related]
10. Medical management of atrial fibrillation: state of the art. Camm J J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S2-6. PubMed ID: 16939435 [TBL] [Abstract][Full Text] [Related]
11. [The clinical challenge of the atrial fibrillation]. de Berrazueta Fernández JR An R Acad Nac Med (Madr); 2007; 124(2):361-78. PubMed ID: 18069601 [TBL] [Abstract][Full Text] [Related]
12. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. Van Gelder IC; Wyse DG; Chandler ML; Cooper HA; Olshansky B; Hagens VE; Crijns HJ; Europace; 2006 Nov; 8(11):935-42. PubMed ID: 16973686 [TBL] [Abstract][Full Text] [Related]
14. Differential recovery of regional atrial contraction after restoration of sinus rhythm after intraoperative linear radiofrequency ablation for atrial fibrillation. Boyd AC; Schiller NB; Ross DL; Thomas L Am J Cardiol; 2009 Feb; 103(4):528-34. PubMed ID: 19195515 [TBL] [Abstract][Full Text] [Related]
15. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital. Allen Lapointe NM; Sun JL; Kaplan S; d'Almada P; Al-Khatib SM Am J Cardiol; 2008 Apr; 101(8):1134-41. PubMed ID: 18394447 [TBL] [Abstract][Full Text] [Related]
16. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy. Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG; J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177 [TBL] [Abstract][Full Text] [Related]
17. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter]. Larsen MT; Lyngborg K; Pedersen F; Corell P Ugeskr Laeger; 2005 Sep; 167(36):3408-12. PubMed ID: 16159494 [TBL] [Abstract][Full Text] [Related]
18. Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablation. Bradley DJ; Shen WK Clin Pharmacol Ther; 2007 Feb; 81(2):284-7. PubMed ID: 17259952 [TBL] [Abstract][Full Text] [Related]
19. Management of atrial fibrillation in patients with heart failure. Efremidis M; Pappas L; Sideris A; Filippatos G J Card Fail; 2008 Apr; 14(3):232-7. PubMed ID: 18381187 [TBL] [Abstract][Full Text] [Related]
20. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG; Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]